Asthenia has been reported as an adverse reaction across 23 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 16,689 adverse event reports mention asthenia in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with asthenia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
Haleon Us Holdings Llc Drugs Reporting Asthenia
The following Haleon Us Holdings Llc drugs have asthenia listed in their FDA adverse event reports, sorted by report count:
Which Haleon Us Holdings Llc drugs cause Asthenia?
23 drug(s) manufactured by Haleon Us Holdings Llc have asthenia listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, and others.
How many Asthenia reports are there for Haleon Us Holdings Llc drugs?
There are a combined 16,689 reports of asthenia across 23 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.